scispace - formally typeset
P

Patrick Paulus

Researcher at Goethe University Frankfurt

Publications -  53
Citations -  2300

Patrick Paulus is an academic researcher from Goethe University Frankfurt. The author has contributed to research in topics: Transplantation & Angiogenesis. The author has an hindex of 25, co-authored 52 publications receiving 2015 citations. Previous affiliations of Patrick Paulus include Medical University of Vienna & University of Vienna.

Papers
More filters
Journal ArticleDOI

Colony-Stimulating Factor-1 Blockade by Antisense Oligonucleotides and Small Interfering RNAs Suppresses Growth of Human Mammary Tumor Xenografts in Mice

TL;DR: It is demonstrated that CSF-1 and CSF -1 receptor are potential therapeutic targets for the treatment of mammary cancer and mouse survival significantly increased after CSf-1 blockade.
Journal ArticleDOI

Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts.

TL;DR: In combination with CMF, anti-CSF-1 Fab reversed chemoresistance of MCF-7 xenografts, suppressing tumor development by 56%, down-regulating expression of theChemoresistance genes breast cancer-related protein, multidrug resistance gene 1, and glucosylceramide synthase, and prolonging survival significantly.
Journal ArticleDOI

Novel aspects of fibrin(ogen) fragments during inflammation.

TL;DR: The state-of-the-art in inflammatory modulation by fibrin(ogen) andfibrin fragments is summarized, however, further research is required to gain better understanding of the entire role fibr in fragments play during inflammation and, possibly, disease development.
Journal ArticleDOI

Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis?

TL;DR: The endothelial integrity, as mechanical barrier against microorganisms and as natural “anticoagulant”, is crucial for physiologic organ function and biomarkers reflecting this special compartment may help in the early detection of systemic inflammation and its complications.
Journal Article

Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice.

TL;DR: The results suggest that human embryonic and colon cancer cells up-regulate host CSF-1 and MMP-2 expression, which could be a novel strategy in treatment of solid tumors.